CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.72
−2.35%Margins
Gross margin
-1732.4%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-69.8%
Return on equity
-64.4%
Return on assets
-72.1%
Return on invested capital
0.00x
Asset turnover
-$5.9M
Cash from operations
$1.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026